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Ebola Reston virus: Philippines
The Ebola Reston virus (ERV) is a virus that has previously been identified in non-human primates from the Philippines, including ones that were
sent to a primate facility in Reston, Virginia. ERV had previously never been documented in pigs. As a result of an increase in mortality in swine
farms, ERV was identified in pigs in Pandi and Talavera (both in Luzon) and in a town outside Manila.
Compelling evidence for pig-to-human transmission now exists. On 23 January 2009, the Philippine Department of Health reported its first
human who was positive for ERV antibodies. This was updated on 30 January 2009 (http://www.who.int/csr/don/2009_02_03/en/index.html)
as there have now been a total of five adults with pig contact, who have been found to be positive for ERV antibodies. These individuals included
a ‘‘backyard pig farmer’’ from Valenzuela City (a neighbourhood within Metro Manila), two farm workers in Bulacon, one farm worker from
Pangasinan, and a butcher from a slaughterhouse in Pangasinan. These men, all between ages 22 and 52 (ProMED-mail archive number
20090131.0437), were reported to be ‘‘in good health’’ and had not had any significant illnesses in the past year.
Dr Craig Pringle, a moderator for ProMED-mail, noted (in ProMED-mail archive number 20090130.0417):
‘‘These low-grade infections suggest that productive infection of humans is rare and that exposure to the virus is not a serious hazard for those
engaged in animal husbandry.’’
‘‘A disquieting feature of these results, however, is that one of the positive sera originated from a backyard farmer, indicating that Ebola-
Reston virus infection of pigs may be widespread in the Philippines.’’
Cholera in Zimbabwe
The horrendous outbreak of cholera in Zimbabwe continues to spread to new areas of the country. This is one of the largest cholera outbreaks
ever recorded, and is far from being brought under control. The most recent posting on ProMED-mail (ProMED-mail archive number
20090204.0491, dated 4 February 2009) reports a total number of 65,739 cases, with a total of 3323 fatalities. The overall case fatality
rate remains very high at 5.1 %, which reflects the overall poor conditions in the country. The ‘acceptable’ case fatality rate should be below
1%. Neighbouring South Africa has also reported 3000 cases, but the strength of its health care and water and sanitation systems have seen the
case fatality rate remain below 1%.
The World Health Organization and other international and local partners are supporting the Ministry of Health and Child Welfare’s efforts to
control the epidemic. Urgent measures needed in Zimbabwe include:
 increasing awareness of prevention and treatment measures.
 making more medicines available at the community level, particularly oral rehydration salts (ORS) and chlorine tablets,
 mobilizing resources to pay Zimbabwean health staff
 opening access to more nongovernmental organizations (NGOs) in more areas of the country
 strengthening the multisectoral response being provided by the United Nations, NGOs, governments and donors.
Further details of these action points can be found on the WHO website at http://www.who.int/mediacentre/news/releases/2009/
cholera_zim_20090130/en/index.html
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Lassa Fever, UK ex-Nigeria
A 66 year old man has died from Lassa fever in a London hospital (ProMED-mail archive number 20090130.0414). The man, originally from
East London, had been travelling in Nigeria and was admitted to hospital soon after returning to the UK on 6 January 2009. Lassa fever was
diagnosed on 22 January 2009. The Health Protection Agency (HPA) stressed that this was an isolated case and there is no risk to the general
public.
As explained on ProMED, Lassa fever is caused by the Lassa virus and is endemic in Nigeria, Sierra Leone, Liberia, Guinea, and the Central
African Republic. Many thousands of people are infected in these countries each year and isolated cases have been seen in Europe and the USA.
There have been 10 confirmed cases of Lassa fever in the UK since 1970.
Around 80% of people infected with Lassa virus develop mild or no symptoms, but in 20 % of cases people will have severe illness. Symptoms
include fever, headache, sore throat, a cough, nausea, vomiting, diarrhoea, and muscle pain. A common complication is deafness. Only about
2% of all patients die from the illness.
